Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Short answer
A hand sanitizer sold as an over-the-counter drug carries two label zones. The front (principal display panel) must state what the product is, using its established name and a statement of its pharmacological category. The “Drug Facts” panel, a boxed block, must present eight required elements in a fixed order under 21 CFR 201.66(c)(1) to (c)(8), from the title “Drug Facts” through the inactive ingredients, and may close with an optional “Questions?” line under (c)(9). This page walks through both, so lab, clinic and supply staff can read a sanitizer label against the regulation instead of against marketing text. It is general product information, not medical advice.
Ask CASRAI · free to tryQuestion about this guide? Ask CASRAI answers with linked sources. 2 free questions a day, no account.
Definition and scope
In this guide “hand sanitizer label” means the labeling of an alcohol-based hand antiseptic regulated by FDA as an over-the-counter (OTC) drug. Two federal rules shape what is printed on it:
- 21 CFR 201.61 (statement of identity) governs the front panel.
- 21 CFR 201.66 (format and content requirements for OTC drug product labeling) governs the Drug Facts panel.
The label is distinct from the ingredient question (which alcohol, what concentration) covered in hand sanitizer ingredients, and from shelf life, covered in hand sanitizer expiration. This page is about where information must appear and how it is formatted.
How the label is organised in practice
The front panel: statement of identity
Under 21 CFR 201.61, the principal display panel must bear, as one of its principal features, a statement of the product’s identity. The identity is given in terms of the established name of the drug, followed by an accurate statement of the general pharmacological category or categories of the drug. The statement is set in bold face, in a size reasonably related to the most prominent printed matter on the panel, and runs in lines generally parallel to the base on which the package rests. The category or action statement sits in direct conjunction with the most prominent display of the proprietary (brand) name.
The Drug Facts box
Under 21 CFR 201.66(c), the required content appears “in the order listed” below. Formatting rules in 201.66(d) set the title and most headings left-justified (the Purpose heading is the exception), the title and headings in bold italic, subheadings in bold, and the whole block set off in a box or similar enclosure by a barline.
Parts of the label: the eight required Drug Facts elements and the optional ninth
Each row below is taken from 21 CFR 201.66, checked on 2026-10-30.
| Order | Element (as titled) | What the regulation says | Paragraph |
|---|---|---|---|
| 1 | Drug Facts | The title of the panel. | (c)(1) |
| 2 | Active ingredient(s) | The active ingredient heading. | (c)(2) |
| 3 | Purpose(s) | The pharmacological action described in the statement of identity is also stated as the purpose. | (c)(3) |
| 4 | Use(s) | The uses heading. | (c)(4) |
| 5 | Warning(s) | Warnings, with bold subheadings; products not intended for ingestion carry “For external use only” in bold type. | (c)(5), (c)(5)(i) |
| 6 | Directions | The directions heading. | (c)(6) |
| 7 | Other information | The other information heading. | (c)(7) |
| 8 | Inactive ingredients | Listed by established name; for OTC drugs that are not also cosmetics, in alphabetical order. | (c)(8) |
| 9 (optional) | Questions? / Questions or comments? | The closing contact heading; the regulation says the label may contain it, not that it must. | (c)(9) |
Warning subheadings
201.66(c)(5) names the bold subheadings that may organise the Warnings element: “Do not use”, “Ask a doctor before use if you have”, “Ask a doctor or pharmacist before use if you are”, “When using this product” and “Stop use and ask a doctor if”. Which of them appear depends on the product. A flammability warning is introduced under 201.66(c)(5)(ii)(C) by a subheading carrying the appropriate flammability signal word or words from the applicable monograph or application, and the children warning in (c)(5)(x) points to the accidental-ingestion statement in 21 CFR 330.1(g).
Type and layout rules
- Subheadings and other text must be no smaller than 6-point type, and the title must be larger than the largest type size used in the panel (201.66(d)(2)).
- Bullets are solid squares or circles, 5-point (201.66(d)(4)).
- The panel is set off in a box or similar enclosure by a barline (201.66(d)(8)).
Reduced format and what “sizes” really refers to
Searchers often pair “label” with “sizes”. The regulation text on this topic is about label surface area, not bottle volume. A reduced format under 201.66(d)(10) applies when the required content needs more than 60 percent of the total surface area available to bear labeling; information required on the principal display panel is excluded from that calculation. In that format the title becomes “Drug Facts (continued)” and may be 7-point, headings may be 7-point or 1-point larger, leading may be tightened as long as ascenders and descenders do not touch, bullets may wrap, and the box may be omitted if the panel is set off by color contrast. The rest of 201.66(d), including items (d)(1), (5), (6) and (7), still applies.
Where it matters for labs, clinics and supply decisions
FDA’s consumer update “Safely Using Hand Sanitizer” (content current as of 04/12/2023, checked 2026-10-30) points readers of alcohol-based hand sanitizer to the Drug Facts label, particularly its warnings section. The checklist below maps each FDA statement to the Drug Facts element where a reader would look for it. The mapping from statement to element is an editorial reading aid; the statements themselves are FDA’s.
| FDA statement | Where to read it on the label |
|---|---|
| FDA found products that “do not contain enough active ingredient (ethyl alcohol or isopropyl alcohol)”; the update cites CDC’s reference to sanitizers containing at least 60% alcohol. | Active ingredient(s), the second element in the box |
| “Hand sanitizer is flammable. Keep hand sanitizer away from heat and flames.” | Warning(s), under the flammability subheading |
| “Store hand sanitizer out of the reach of pets and children” | Warning(s), where the children statement appears (see 21 CFR 330.1(g), referenced by 201.66(c)(5)(x)) |
| FDA found products with food flavors or fragrances such as chocolate or raspberry. | Inactive ingredients, listed by established name in alphabetical order |
FDA also maintains a list of hand sanitizers to avoid at https://www.fda.gov/handsanitizerlist. For related reading, see how to use hand sanitizer, types of disinfectants and what is an alcohol swab. Drug labeling for prescription products follows different sections of the same part of the regulations; see FDA prescription drug labeling (201.56 and 201.57).
Common misunderstandings
- “The label size rule is about the bottle.” The reduced format is tied to the share of available labeling surface the required content needs (60 percent), not to bottle volume.
- “Drug Facts can be arranged any way.” The eight required elements, plus the optional Questions? line when it is used, must appear in the listed order, and the title and headings follow set formatting.
- “The front panel and Drug Facts say the same thing.” The front panel carries the statement of identity in bold, with the pharmacological category next to the brand name; the Drug Facts panel carries the structured content and, in the Purpose element, restates the pharmacological action.
- “Any text smaller than the title is acceptable.” Subheadings and other text may be no smaller than 6-point type in the standard format.
FAQ
What is on a hand sanitizer label?
A front-panel statement of identity (established name plus pharmacological category) and a boxed Drug Facts panel with active ingredient(s), purpose(s), use(s), warning(s), directions, other information, inactive ingredients and a questions line, in that order (21 CFR 201.61 and 201.66).
What size must the print be?
Under 21 CFR 201.66(d)(2), subheadings and other text must be no smaller than 6-point type, and the title must be larger than the largest type size used. The reduced format in (d)(10) allows 7-point headings and a “Drug Facts (continued)” title when the content needs more than 60 percent of the available labeling surface.
Where do I find the warnings?
In the Warning(s) element, the fifth item in the Drug Facts box. FDA specifically advises reading that section.
Sources
- 21 CFR 201.66, Format and content requirements for OTC drug product labeling: https://www.law.cornell.edu/cfr/text/21/201.66, checked 2026-10-30.
- 21 CFR 201.61, Statement of identity: https://www.law.cornell.edu/cfr/text/21/201.61, checked 2026-10-30.
- FDA, Safely Using Hand Sanitizer (content current as of 04/12/2023): https://www.fda.gov/consumers/consumer-updates/safely-using-hand-sanitizer, checked 2026-10-30.







